BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 27221705)

  • 1. MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.
    Chen YF; Yang CC; Kao SY; Liu CJ; Lin SC; Chang KW
    Cancer Res; 2016 Aug; 76(16):4872-86. PubMed ID: 27221705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
    Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
    Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral-specific ablation of Klf4 disrupts epithelial terminal differentiation and increases premalignant lesions and carcinomas upon chemical carcinogenesis.
    Paparella ML; Abrigo M; Bal de Kier Joffe E; Raimondi AR
    J Oral Pathol Med; 2015 Nov; 44(10):801-9. PubMed ID: 25605610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression.
    Tseng SH; Yang CC; Yu EH; Chang C; Lee YS; Liu CJ; Chang KW; Lin SC
    Int J Cancer; 2015 Mar; 136(6):1263-75. PubMed ID: 25082302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
    Cai Z; Hao XY; Liu FX
    Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
    Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW
    Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
    Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
    Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of syngeneic murine model for oral cancer therapy.
    Chen YF; Chang KW; Yang IT; Tu HF; Lin SC
    Oral Oncol; 2019 Aug; 95():194-201. PubMed ID: 31345390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
    Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
    J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing of mouse oral carcinoma cell lines derived from transgenic mice and their use as syngeneic tumorigenesis models.
    Chen YF; Liu CJ; Lin LH; Chou CH; Yeh LY; Lin SC; Chang KW
    BMC Cancer; 2019 Mar; 19(1):281. PubMed ID: 30922255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
    Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
    J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4NQO induced carcinogenesis: A mouse model for oral squamous cell carcinoma.
    Sagheer SH; Whitaker-Menezes D; Han JYS; Curry JM; Martinez-Outschoorn U; Philp NJ
    Methods Cell Biol; 2021; 163():93-111. PubMed ID: 33785171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The increase of oncogenic miRNA expression in tongue carcinogenesis of a mouse model.
    Kao YY; Tu HF; Kao SY; Chang KW; Lin SC
    Oral Oncol; 2015 Dec; 51(12):1103-12. PubMed ID: 26525105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
    Li L; Ma HQ
    Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin suppresses the tumorigenesis of oral squamous cell carcinoma by regulating microRNA-22/WNT1/β-catenin axis.
    Zhang C; Hao Y; Sun Y; Liu P
    J Pharmacol Sci; 2019 Jun; 140(2):128-136. PubMed ID: 31257059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.